Jump to content

Property:Funding

From CAMIH

This is a property of type Text.

Showing 20 pages using this property.
K
Support from Willpharma BV for the provision of the ointments. The sponsor was not involved in the design and conduct of the study.  +
Funding for support of research and clinical trials from the following companies: AstraZeneca; Bristol-Myers Squibb; Celgene, Inc.; Novartis Pharmaceutical Company, Inc.; Genentech-Roche, GlaxoSmithKline, and Pfizer. Study agent but no funding has been provided by DSM and Pfizer for trials conducted by Dr. Fabian.  +
"This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic and was supported in part by Public Health Service grants CA-25224, CA-37404, CA-35113, and 124477."  +
This work was supported financially by Grants-in-Aid for Science Research from the Ministry of Education, Science, Sports and Culture, Japan (Project no. 15K10047).  +
This study was supported by the Alfried-Krupp-von-Bohlen-und-Hahlbach Foundation (Graduate Schools Tumour Biology and Free Radical Biology), the Deutsche Krebshilfe/Dr. Mildred-Scheel-Stiftung (109102), the Deutsche Forschungsgemeinschaft (DFGgRK840-E3/E4, MA 4115/1-2/3, NI 1297/1-1), the Federal Ministry of Education and Research (BMBFgANI-MED 03152061A and BMBF 0314107), and the European Union (EU-FP-7: EPC-TM and EU-FP7-REGPOT-2010-1). KK and SG both received a Gerhard-Domagk-Stipendium of Greifswald University Medicine made possible through unrestricted educational grants from Medinal GmbH, Greven, Germany, Fresenius Kabi Germany GmbH, Bad Homburg, Germany, and Nutricia GmbH, Erlangen, Germany. L-Carnitine bulk compound was kindly provided by Lonza Ltd., Basel, Switzerland.  +
L
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Peking Union Medical College Hospital.  +
This work was supported by Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD, USA. The efforts of A.H. Lichtman were supported by the Virginia Commonwealth University School of Pharmacy start-up funds.  +